Birinyi Associates Inc Pfizer Inc Transaction History

Birinyi Associates Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $16,366 - $21,364	-392 Reduced 6.22%	5,908 $302,000
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $10,940 - $13,355	250 Added 4.13%	6,300 $276,000
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $2,326 - $2,758	50 Added 0.83%	6,050 $317,000
Q1 2022 Apr 05, 2022	BUY	$45.75 - $56.69 $9,150 - $11,338	200 Added 3.45%	6,000 $311,000
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $22,726 - $33,687	550 Added 10.48%	5,800 $342,000
Q2 2021 Aug 05, 2021	BUY	$35.91 - $40.68 $188,527 - $213,570	5,250 New	5,250 $206,000
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $293,670 - $356,265	-9,750 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $114,877 - $164,135	-4,250 Reduced 30.36%	9,750 $318,000
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $251,797 - $326,507	-7,750 Reduced 35.63%	14,000 $503,000
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $18,750 - $20,600	500 Added 2.35%	21,750 $924,000
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $96,175 - $109,650	2,500 Added 13.33%	21,250 $928,000
Q3 2018 Nov 01, 2018	SELL	$34.47 - $41.81 $8,617 - $10,452	-250 Reduced 1.32%	18,750 $826,000
Q1 2018 Apr 26, 2018	BUY	$31.91 - $37.02 $23,932 - $27,765	750 Added 4.11%	19,000 $674,000
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $49,890 - $52,935	1,500 Added 8.96%	18,250 $661,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $69,750 - $76,837	2,250 Added 15.52%	16,750 $598,000
Q2 2017 Aug 08, 2017	BUY	N/A	14,500	14,500 $487,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Birinyi Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Birinyi Associates Inc with notifications on news.